Roche Holding AG (via businesspartner.roche.com portal)
↗Basel, Switzerland
F. Hoffmann-La Roche AG is a Swiss multinational healthcare company and one of the world's largest pharmaceutical and diagnostics corporations. The company operates through two primary divisions: Pharmaceuticals and Diagnostics. Roche is the fifth-largest pharmaceutical company globally by revenue and the leading provider of cancer treatments, with approximately 103,249 employees worldwide. The company operates through wholly-owned subsidiaries including Genentech (USA) and holds majority stake in Chugai Pharmaceutical (Japan), alongside partnerships with over 250 global collaborators. Roche pairs a leading biopharmaceutical business with the world's largest diagnostics franchise, enabling precision medicine at scale across oncology, immunology, neurology, ophthalmology, and other therapeutic areas.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Big Pharma - Integrated Pharmaceutical & Diagnostics
SIZE & FINANCIALS
Employees:10000+
Revenue:$76.2B (2025 trailing 12-month)
Founded:1896
Ownership:public
Status:operating
STOCK
Exchange:SIX Swiss Exchange
Ticker:ROG
Market Cap:$373.88B (Feb 2026)
PIPELINE
Stage:Phase 1 through Commercial
Lead Drug Stage:Multiple Phase 3 assets (trontinemab/Alzheimer's, giredestrant/breast cancer, fenebrutinib/MS, NXT007/hemophilia A)
Modalities:Small molecule, Monoclonal antibodies (mAb), Bispecific antibodies, Antibody-drug conjugates (ADC), Cell therapy (CAR-T), Biologics
Active Trials:150
Trial Phases:Phase 1: 15 | Phase 2: 35 | Phase 3: 25 | Phase 4: 20
FDA Approvals:23
EMA Approvals:18
CORPORATE STRUCTURE
Subsidiaries:Genentech (100% subsidiary, USA), Chugai Pharmaceutical (majority stake, Japan)
Key Partnerships:Jazz Pharmaceuticals (oncology collaboration), Daiichi Sankyo & AstraZeneca (AI diagnostic for DATROWAY), Broad Clinical Labs (NGS technology for neonatal sequencing), Zealand Pharma (petrelintide co-development for cardiometabolic diseases)
COMPETITION
Position:Leader
Competitors:Novartis (revenue $45.4B), Pfizer (revenue $58.5B - largest), AstraZeneca (revenue $45.8B), Johnson & Johnson, Merck, Sanofi, AbbVie, GSK
LEADERSHIP
Key Executives:
Thomas Schinecker - Chief Executive Officer
Severin Schwan - Chairman of the Board
Alan Hippe - Chief Financial Officer
Cristina A. Wilbur - Chief People Officer
Teresa Graham - CEO, Roche Pharmaceuticals
Matt Sause - CEO, Roche Diagnostics
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Roche Holding AG (via businesspartner.roche.com portal) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Roche Holding AG (via businesspartner.roche.com portal). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.